2020 Online Salon
PTX-022 Mechanism of Action
Project Detail
- Company/Institution: Nucleus Medical Media
- Submission Type: Company/Corporation Submission
- Other Contributors:
- Address: Kennesaw, Georgia USA
- Client: Palvella Therapeutics
- Copyright: 2019 © Nucleus Medical Media
- Medium/software used: Cinema 4D, After Effects CC
- Final presentation format: HD, Online video
- Primary Audience: Educated investors
Project Description
The purpose of this animation is to promote the potential of the topical drug PTX-022 to treat Pachyonychia congenita (PC) by showing its unique method of transporting rapamycin through the skin via proprietary QTORIN technology to inhibit the mutant activity of affected keratinocytes.